Podcasts: Advocate for Pathology

This month we'll review the proposed 2023 Medicare Payment Regulations released by the CMS, the technical reporting changes made to CLIA proficiency testing regulations, as well as the declaration of Mpox as a global health emergency and a public health emergency in the United States. We will also be joined by Theresa Emory, MD, FCAP, to talk about good faith estimate requirements as they relate to surprise medical bills.

This month we'll look at updates on the VALID Act, examine the CDC announcement for Mpox specimen guidelines, and review the decision by the CMS to retain diagnostic codes for next-generation sequencing.

This month we'll be focusing on the VALID Act and its impact on laboratory-developed tests. We sat down with CAP President Dr. Emily Volk to get some background on the legislation and what to expect moving forward.

This month we recognize National Minority Health Month, look at the request for additional COVID funding, learn about new efforts in pandemic preparedness, and review highlights from this year's pathologists leadership summit with Vaishali Pansare, MD, FCAP.

This month we'll look at recent efforts to strengthen the national blood supply, the passing of an omnibus bill by Congress, and the latest updates about the PREVENT Pandemics Act.

This month we’ll look at the Biden administration's relaunch of its cancer moonshot initiative, addressing social determinants of health, and more.

This month we'll look at testing supply shortages caused by the Omicron variant, new dispute guidelines in the No Surprises Act, and more.

The CAP is advocating to make the IDR process truly independent and fair to all participants. We spoke with Dr. Theresa Emory, chair of the CAP's Payment Policy Subcommittee, to learn more.

This month we'll look at a lawsuit involving the implementation of the No Surprises Act, the efforts of Congress to mitigate Medicare cuts, and more.

We sat down with four pathologists to discuss their experience and how other pathologists can work with the CAP to get involved in effective advocacy.

In this recap, we review the final Medicare fee schedule regulations, updates from Cigna, and more.

For this episode, we have a conversation with Dr. Richard Eisner to discuss the CAP’s Virtual fly-in to Capitol Hill that he participated in to urge members of Congress to mitigate future cuts to Medicare. As well as Cigna PC of CP updates, news from Capitol Hill, and more.

In this CAPcast we spoke with Kathryn Knight, MD, FCAP about the CAP’s annual meeting and the advocacy town hall she moderated. Other stories include FDA network of experts admission, updates on CAP advocacy in regards to the reconciliation bill in Congress, and more.

In this inaugural CAP Advocacy Recap, we will review the CAP's opposition to a recent VA initiative, take a look at the 3.5 trillion dollar infratructure bill in Congress, and we'll sit down with Dr. Jonathan Myles, chair of the Council on Government and Professional Affairs, to discuss what pathologists need to know about the proposed 2022 Medicare Physician Fee Schedule.

In this CAPcast we are joined by Joe Saad, MD, FCAP, vice chair of the Council on Government and Professional Affairs, and Walter Klein, MD, FCAP, who has participated in virtual lobbying meetings with his members of Congress and has attended previous CAP Hill Days. They will get into greater detail and give pathologists tips on how to conduct a virtual meeting with a senator or representative in Congress.

The CAP's Advocacy efforts have included several touchpoints with the Administration and Congress. In this CAPcast, Jonathan Myles, MD, FCAP, will discuss the CAP’s actions this year to influence the government’s response to the pandemic.

Recent U.S. physician workforce counts have understated by about 40% the number of actively practicing pathologists. In this CAPcast interview, two CAP member leaders—past president Stanley Robboy and Governor Dr. Donald Karcher—provide background on the misevaluation, its impact, and future policy implications of their new research.

In this CAPcast, Dr. David Gang and Dr. Matthew Foster-two leaders with the CAP’s Federal and State Affairs Committee--discuss their recent trips to Capitol Hill to meet with their legislators on surprise billing.